ADPKD, Tolvaptan, and Nephrolithiasis Risk.

ADPKD, Tolvaptan, and Nephrolithiasis Risk. Clin J Am Soc Nephrol. 2020 Jun 11;: Authors: Hoorn EJ, Zietse R PMID: 32527947 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32527947?dopt=Abstract

Source: Clinical Journal of the American Society of Nephrology : CJASN - June 10, 2020 Category: Urology & Nephrology Authors: Hoorn EJ, Zietse R Tags: Clin J Am Soc Nephrol Source Type: research

More News: Kidney Stones | Urology & Nephrology